A systematic review of economic evaluations of pharmacological treatments for active tuberculosisFRONTIERS IN PUBLIC HEALTHIF3.42024-04-160OAAI
The prevalence of drug patent term extensions in the United States, 2000-2018NATURE BIOTECHNOLOGYIF41.72023-07-144PRE
Broad Patent Claims Come Before the Supreme Court in Amgen v SanofiJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552023-05-163OA
Five-Year Sales for Newly Marketed Prescription Drugs With and Without Initial Orphan Drug Act DesignationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552023-05-098OA
US public investment in development of mRNA covid-19 vaccines: retrospective cohort studyBMJ-BRITISH MEDICAL JOURNALIF42.72023-03-0124OAAI
Recent Patent Reform Bills and Their Implications for Prescription DrugsJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552023-02-140PRE
Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022JAMA HEALTH FORUMIF11.32023-01-2729OAAI
A Patient in His 50s With Chest Tightness and Left Arm and Neck TinglingJAMA CARDIOLOGYIF14.12022-10-120PRE
New international pandemic treaty: potential implications for clinicians worldwidePOSTGRADUATE MEDICAL JOURNALIF2.72021-09-110OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项